2514 related articles for article (PubMed ID: 7669741)
1. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
Mérel P; Hoang-Xuan K; Sanson M; Moreau-Aubry A; Bijlsma EK; Lazaro C; Moisan JP; Resche F; Nishisho I; Estivill X
Genes Chromosomes Cancer; 1995 Jul; 13(3):211-6. PubMed ID: 7669741
[TBL] [Abstract][Full Text] [Related]
2. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
3. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
4. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
5. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
6. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.
Szijan I; Rochefort D; Bruder C; Surace E; Machiavelli G; Dalamon V; Cotignola J; Ferreiro V; Campero A; Basso A; Dumanski JP; Rouleau GA
Neuromolecular Med; 2003; 3(1):41-52. PubMed ID: 12665675
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
9. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
10. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
[TBL] [Abstract][Full Text] [Related]
11. Truncated NF2 proteins are not detected in meningiomas and schwannomas.
Den Bakker MA; van Tilborg AA; Kros JM; Zwarthoff EC
Neuropathology; 2001 Sep; 21(3):168-73. PubMed ID: 11666013
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bono P; Grammatico B; Grammatico P; Radice P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):638-41. PubMed ID: 8655145
[TBL] [Abstract][Full Text] [Related]
13. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
17. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
[TBL] [Abstract][Full Text] [Related]
18. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
19. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
